Obdobje:
Arunima Murgai ... [et al.]Targeting the deubiquitinase USP7 for degradation with PROTACsChemical communications, 2022, Vol. 58, iss. 61, str. 8858-8861https://pubs.rsc.org/en/content/articlelanding/2022/cc/d2cc02094g
Péter Ábrányi-Balogh ... [et al.]Next-generation heterocyclic electrophiles as small-molecule covalent MurA inhibitorsPharmaceuticals, 2022, Vol. 15, iss. 12, art. 1484, 2022, 10 str.https://www.mdpi.com/1424-8247/15/12/1484
Samo Guzelj ... [et al.]Lipidation of NOD2 agonists with adamantane and stearoyl moieties differentially regulates their In vivo adjuvant activityPharmaceutics, 2022, Vol. 14, iss. 12, art. 2755, 9 str.https://www.mdpi.com/1999-4923/14/12/2755
Nanca Cebron Lipovec, Andrej Anderlic, and Igor Locatelli General antidepressants prescribing trends 2009–2018 in Slovenia: a cross-sectional retrospective database studyInternational journal of psychiatry in clinical practice, 2022, Vol. 26, iss. 4, str. 401-405https://www.tandfonline.com/doi/full/10.1080/13651501.2022.2057331
Samo Guzelj, Špela Bizjak, and Žiga JakopinDiscovery of desmuramylpeptide NOD2 agonists with single-digit nanomolar potencyACS Medicinal Chemistry Letters, 2022, Vol. 13, iss. 8, 2022, str. 1270-1277https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00121
Anže Meden ... [et al.]Pseudo-irreversible butyrylcholinesterase inhibitors: SAR, kinetic, computational, and crystallographic study of the N-dialkyl O-arylcarbamate warheadChemRxiv, 2022, str. 1-56https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62f0fc5069f3a57e38afcb23/original/pseudo-irreversible-butyrylcholinesterase-inhibitors-sar-kinetic-computational-and-crystallographic-study-of-the-n-dialkyl-o-arylcarbamate-warhead.pdf
Samo Guzelj ... [et al.]Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiators Journal of medicinal chemistry, 2022, Vol. 65, no. 22, str. 15085–15101https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c00808#
Živa Zajec ... [et al.]Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcomaBioorganic chemistry, 2022, Vol. 131, 2022, str. 1-16https://www.sciencedirect.com/science/article/pii/S0045206822007179
Matic Proj ... [et al.]Fragment-sized thiazoles in fragment-based drug discovery campaigns: friend or foeACS Medicinal Chemistry Letters, 2022, Vol. 13, iss. 12, str. 1905–1910https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00429
Vid Vičič ... [et al.]Assessment of Vitamin D status in Slovenian premenopausal and postmenopausal women, using total, free, and bioavailable 25-hydroxyvitamin D (25(OH)D)Nutrients, 2022, Vol. 14, iss. 24, art. 5349, 12 str.https://www.mdpi.com/2072-6643/14/24/5349